PAMELA HUHN: Open Payments
NPI 1750750477 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,257 in 77 payments from 20 companies in 2025. Trend: 2023 $964 · 2024 $1,163 · 2025 $1,257
Food & beverage: $1,252Education: $5
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 7 | $181 |
| ANI Pharmaceuticals, Inc. | 13 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $138 |
| Novartis Pharmaceuticals Corporation | 7 | $128 |
| Otsuka America Pharmaceutical, Inc. | 5 | $112 |
| Amgen Inc. | 4 | $68 |
| Mallinckrodt Hospital Products Inc. | 3 | $57 |
| Daiichi Sankyo Inc. | 3 | $56 |
| Ardelyx, Inc. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
Products named: TARPEYO, PURIFIED CORTROPHIN GEL, Kerendia, JYNARQUE, Fabhalta, Vanrafia, INJECTAFER, IBSRELA.
Industry payments across OH — which companies pay providers there.
